Policy Director in the Office of the National Coordinator for Health Information Technology Jodi G. Daniel Joins Crowell & Moring
Firm News | 3 min read | 10.20.15
Washington, D.C. – October 20, 2015: Crowell & Moring LLP today announced that Jodi G. Daniel, the former director of the Office of Policy in the Office of the National Coordinator for Health Information Technology (ONC), U.S. Department of Health and Human Services (HHS), joined the firm as a partner in its Health Care Group. Daniel served for a decade as the director at the ONC and 15 years at HHS, where she helped spearhead important changes in health information privacy and health information technology to improve health care for consumers nationwide.
Based in the firm's Washington, D.C. office, Daniel will provide strategic advice to clients navigating the legal and regulatory environments related to technology in the health care sector.
For more than 10 years, Daniel has been responsible for thought leadership, policy development, and identifying policy drivers for health IT activities within the federal government, and ultimately established the HHS' national health IT policy. As former director at the ONC, Daniel addressed privacy and security issues to ensure that there was clear guidance on how the initial Health Insurance Portability and Accountability Act of 1996 (HIPAA) rules applied to health IT. She set the strategic direction and set policy on consumer e-health and health IT safety. She is also credited with establishing the ONC's regulatory capacity and led the development of all ONC regulations on health IT standards and certification.
"Jodi literally wrote the book—and all the rules—governing health information technology, including the complex HIPAA privacy and enforcement rules," said John T. Brennan, Jr.,chair of the firm's Health Care Group. "Her experience in setting the regulatory framework and policies for both technology providers and adopters has supported innovation in areas including mobile health, remote devices and telehealth, and that insight will be of enormous value to our clients as they operate in this highly regulated space."
"Technology is changing the face of health care and health care delivery," said Daniel. "To meet this growing need, the private sector and the government must continue to work together from a legal and policy perspective. I look forward to building on Crowell & Moring's deep bench in the health care arena, and to incorporate health IT into the firm and counsel clients as they forge a path into this highly regulated space."
As the first senior counsel for health information technology in the Office of the General Counsel (OGC) of HHS, Daniel developed HHS's foundational legal strategies and coordinated all legal advice regarding health IT for HHS. She founded and chaired the health information technology practice group within OGC and worked closely with the Centers for Medicare and Medicaid Services in the development of the e-prescribing standards regulations and the Stark and anti-kickback rules regarding e-prescribing and electronic health records.
Daniel earned her J.D., magna cum laude, Order of the Coif, from Georgetown University, her M.P.H. from Johns Hopkins University, and her B.A., cum laude, from Tufts University. She is admitted to practice in the District of Columbia and New York.
Crowell & Moring LLP is an international law firm with approximately 500 lawyers representing clients in litigation and arbitration, regulatory, and transactional matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation, as well as its ongoing commitment to pro bono service and diversity. The firm has offices in Washington, D.C., New York, Los Angeles, San Francisco, Orange County, Anchorage, London, and Brussels.
Insights
Firm News | 1 min read | 03.11.25
Crowell & Moring Represents Nuclear Energy Startup Atomic Alchemy in its Acquisition by Oklo
March 11, 2025: Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced on March 5, 2025 that it has closed the $25 million acquisition of Crowell client Atomic Alchemy Inc. (“Atomic Alchemy”), a leading innovator in radioisotope production. Oklo intends to use this strategic acquisition to establish a more reliable domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors and provides synergies to Oklo’s fuel recycling and nuclear energy businesses. Demand for radioisotopes is expected to increase significantly over the next decade, while global supply struggles to keep pace due to aging reactor infrastructure and a fragmented global supply chain, which at present is dominated by countries outside the United States. Atomic Alchemy intends to be a low-cost U.S. radioisotope producer that can provide a secure and domestic supply of radioisotopes to U.S. companies commercializing innovative radioisotope applications. With its proprietary VIPR® technology, Atomic Alchemy is building the first scalable production facility to provide a reliable, sustainable source of high-value radioisotopes. Using a vertically integrated model and fuel recycling, in partnership with Oklo, Atomic Alchemy is transforming isotope production to address global shortages, support critical applications, and strengthen national security. The core deal team included Samuel Holland Edwards, Jon O’Connell, Justin Lurie, and Ryan Flynn.
Firm News | 2 min read | 03.11.25
Daily Journal Honors Crowell & Moring Victory in University of California Case
Firm News | 2 min read | 03.11.25
Foreign Investment Watch Names Caroline Brown a Top Advisor 2025
Firm News | 2 min read | 03.07.25
Crowell & Moring Attorneys Honored With 2025 Burton Award for Distinguished Legal Writing